Neurofeedback & qEEG Research Library
Neurofeedback has been explored after traumatic brain injury for attention, cognitive functioning and self-regulation. Reviews describe potential benefit while emphasizing weak study designs and limited samples.
Why this finding matters
After brain injury, even modest difficulties with attention, fatigue or regulation can have a large effect on daily life. Neurofeedback is feasible and promising, but small samples and weak study designs mean expectations must remain measured.
Research Spotlight
Feasible, but evidence remains limited
- Cognition studied
- Productivity outcomes studied
- Small samples
- Study quality concerns
What the evidence suggests
The available literature includes feasibility studies, controlled trials and rehabilitation reports. Some participants improved on cognitive or functional measures, but the evidence is not yet sufficient to define a universal protocol.
What this could mean for you
A concussion pathway should begin with assessment of symptoms, recovery course, sleep, mood, pain, cognition and return-to-work or school demands. Neurofeedback may be one component of a broader plan.
A careful, individualized next step
Research informs—but does not replace—individual clinical judgment. We review symptoms, diagnosis, previous treatment, medications, contraindications, functional goals and the strength of evidence for the proposed protocol. A consultation does not guarantee that treatment will be recommended.
Build the right recovery pathway
A consultation can help determine whether neuropsychological assessment, rehabilitation, psychological care or neurofeedback best fits the current needs.
Book a Consultation Explore the related Calgary service
Related Calgary service: Neurofeedback Calgary
Study citation
Chen et al. Effects of neurofeedback on cognitive function and productive activity following traumatic brain injury. PMID: 37125901.
View the original record on PubMed
Educational information only. Findings from pooled research do not predict individual outcomes and may involve devices or protocols that differ from EXOMIND.